Medicare copays for new Alzheimer's drug could reach $11,500

  • 📰 ABC
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

A new report says the $56,000 Alzheimer’s drug approved this week would raise Medicare premiums broadly.

The FDA approved Biogen’s Aducanumab after its own independent recommended that it be rejected.WASHINGTON -- A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday.

The chairman of the Senate Finance Committee, Democratic Sen. Ron Wyden of Oregon, said the list price for the Alzheimer's drug was “unconscionable.” Although Presidenthas called for granting Medicare negotiating authority, prospects for the bill are uncertain. Medicare has not made a formal determination on covering Aduhelm, but cost traditionally does not enter into such considerations. Drugmaker Biogen has said it priced Aduhelm responsibly.

Beyond monthly premiums, there would also be impacts on out-of-pocket costs. Many patients taking the medication, including those signed up in Medicare Advantage plans from private insurers, could face thousands of dollars in copayments,. The maximum could reach about $11,500, researchers estimated. Biogen, which developed the Alzheimer's drug with Japan’s Eisai Co., said earlier this week that it expects a gradual uptake and not a sharp “hockey-stick” spike.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

F*cking insane

that is absolutely outrageous. the govt should regulate these prices but it's understandable that they won't bite the hand that feeds them.

Greed

Another fake cure to get rich

sweet! no money left over. starvation is always an option.

💆🏿‍♀️both of 'em

lmao...yeah okay. They don't even care we know they're all crooks.

There is no reason on earth it should be that expensive other than greed.

Go broke and live longer or die slowly

Democrats are going to bankrupt us all.

Can’t even cure

7 ways to increase your blood Oxygen to avoid any complications Lack of oxygen weakens every bodily system and is the main cause of disease.

Fix wealthcare system. Also probably could get meds cheaper in canada and mexico.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 471. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NPR Cookie Consent and ChoicesMy RA treatment thru medicare is $6,000 A MONTH. I’m on disability. I live on $900/ month. Needless to say, my RA goes untreated. SenSanders We hope this sets off a wave of conscience-fueled resignations at pharmaceutical companies, which though they have helped with Vaccines they are raking in the money and hurting poor people - not the Beloved Community we are supposed to create on Earth. The pricing of this drug is not feasible for most. It's already crazy expensive to pay for a loved ones care in 24/7 in a nursing home.
Source: NPRHealth - 🏆 144. / 63 Read more »

Third member of prestigious FDA panel resigns over approval of Biogen's Alzheimer's drugA third member of a key FDA panel has resigned over the agency's controversial decision to approve Biogen's new Alzheimer's drug, Aduhelm, CNBC has learned. Things that make you go hmmmm FDA is a scam. just like the IRS Amyloid plaques are a symptom more than a cause, so I am skeptical but we will see
Source: CNBC - 🏆 12. / 72 Read more »

Why a COVID Diagnosis Could Cost You More in 2021New research suggests COVID-19 could be a much more expensive experience for folks who fall ill this year, thanks to the return of deductibles and copays.
Source: WebMD - 🏆 709. / 51 Read more »

Two doctors have resigned from a prestigious panel after FDA approved a controversial Alzheimer's drugBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Two members of U.S. FDA advisory panel resign over Alzheimer's drug approvalTwo members of a panel of outside advisors to the U.S. Food and Drug Administration have resigned in protest at the agency's decision to approve Biogen Inc's (BIIB.O) Aduhelm for treatment of Alzheimer's disease despite the committee’s recommendation against doing so. newborn NotaryServices SpainNATO Navy_JAG AF JAG
Source: Reuters - 🏆 2. / 97 Read more »

Two members of FDA panel resign in protest over Alzheimer's drug approvalThe 11-member committee voted nearly unanimously in November that Biogen's drug should not be approved, citing inconclusive evidence.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »